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Abstract
Background: Panax notoginseng is commonly used for the treatment of cardiovascular diseases in China. The
present study investigates the effects of three different saponin fractions (ie total saponins, PNS; protopanaxadiol-
type saponin, PDS; and protopanaxatriol-type saponin, PTS) and two major individual ingredients (ie ginsenoside
Rg1 and Rb1) from P. notoginseng on the endothelial inflammatory response in vitro and in vivo.
Methods: Recombinant human tumor necrosis factor-a (TNF-a) was added to the culture medium of human
coronary artery endothelial cells (HCAECs) to induce an inflammatory response. A cell adhesion assay was used to
determine the effect of the P. notoginseng saponin fractions on endothelial-monocyte interaction. The cell
adhesion molecule (CAMs) expression, including ICAM-1 and VCAM-1, in the protein level on the surface of
endothelial cells were measured by cellular ELISA. CAMs expression in mRNA level was also assayed by qRT-PCR in
the HCAECs and the aorta of rat fed with high cholesterol diet (HCD). Western blotting was used to detect effect
of the saponin fractions on CAMs protein expression in HCAECs. In addition, nuclear translocation of p65, a
surrogate marker for NF-B activation, was measured by immunostaining.
Results: Three saponin fractions and two individual ginsenosides exhibited the inhibitory effects on monocyte
adhesion on TNF-a-activated HCAECs and expression of ICAM-1 and VCAM-1 at both mRNA and protein levels in
vitro. The saponin fractions exhibited a similar trend of the inhibitory effects on the mRNA expression of CAMs in
the aorta of HCD-fed rat in vivo. These inhibitory effect of saponin fractions maybe attribute partially to the
suppression of the TNF-a-induced NF-B activation.
Conclusion: Our data demonstrate that saponin fractions (ie PNS, PDS and PTS) and major individual ginsenosides
(ie Rg1 and Rb1) have potential anti-atherogenic effects. Among the tested saponin fractions, PDS is the most
potent saponin fraction against TNF-a-induced monocyte adhesion as well as the expression of adhesion
molecules in vitro and in vivo.
Background
Atherosclerosis (AS), a progressive disease characterized
by the accumulation of lipids and fibrous elements in
the large arteries, is the cause of most human heart dis-
eases and strokes [1]. The role of vascular inflammation
in atherosclerosis has been increasingly recognized in
the past decade [2,3]. The early phase of vascular
inflammation involves the recruitment of inflammatory
monocytes from the circulation into the sub-endothe-
lium, where they ingest lipid and become foam cells.
This process is mediated predominantly by adhesion
molecules, such as intercellular adhesion molecule-1
(ICAM-1) and vascular cell adhesion molecule-1
(VCAM-1) on the surface of vascular endothelium. Up-
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regulation of these adhesion molecules on endothelial
cells is important in the initial stage of the inflammatory
response in atherosclerosis [3,4]. Much interest is now
focused on the determination of the therapeutic value of
the inhibitors of endothelium-leukocyte adhesion.
The extract of Panax notoginseng has long been pre-
scribed for the treatment of coronary heart diseases in
China [5]. We recently showed that the total saponins
from P. notoginseng (PNS) dramatically reduced the
extent of atherosclerotic lesion in apolipoprotein E (Apo
E)-deficient mice and that effect was associated with an
anti-vascular inflammatory activity [6]. PNS is a chemi-
cal mixture containing more than 50 different saponins
[5] and are classified into two main groups, namely the
20(S)-protopanaxatriol saponins (PTS), such as ginseno-
side Rg1, and the 20(S)-protopanaxadiol saponins (PDS),
such as ginsenoside Rb1 [5,7]. PDS and PTS showed
diverse or even antagonistic pharmacological activities
[8-11]; however, the active chemical component(s) in
the PNS fraction responsible for the anti-vascular
inflammation and the underlying molecular mechanism
are largely unknown.
This study examines the anti-vascular inflammatory
effects of three saponin fractions and two individual gin-
senosides on the TNF-a-activated human coronary
artery endothelial cells (HCAECs). The anti-vascular
inflammatory action of the three saponin fractions is
further evaluated by determining the mRNA expression
of cell adhesion molecules (CAMs) in the aorta of high-
cholesterol diet (HCD)-fed rats in vivo.
Methods
Quality control of chemical fractions
PNS (> 95% pure) was purchased from Wanfang Natural
Pharmaceutical Company (China). In our laboratory,
PTS and PDS were previously separated from PNS by
DS-401 macroporous resins eluted with 30% and 80%
(v/v) aqueous ethanol solutions respectively [7]. Ginse-
nosides Rb1 and Rg1 were purchased from the National
Institute for the Control of Pharmaceutical and Biologi-
cal Products (China). To ensure the consistency of effi-
cacy, we determined the chemical characteristics of
these fractions, including PNS, PTS and PDS using
HPLC-UV. An Aglient 1100 series HPLC apparatus
(USA) was operated under optimized conditions [12,13].
HPLC-grade acetonitrile was purchased from Merck
(Germany). De-ionized water was prepared by a Milli-Q
purification system (USA).
Animals and treatment
Male Sprague-Dawley rats (170 ± 10 g), purchased from
Guangdong Provincial Medical Laboratory Animal Cen-
ter (China), were maintained on a 12-hour dark/light
cycle in air-conditioned rooms (25 ± 2°C, 50 ± 5%
humidity) with access to food and water ad libitum.
After acclimation for one week, the rats were randomly
assigned to nine groups (n = 8 per group). Group 1
(control) was fed a standard rat chow (~14% protein,
~10% fat and ~76% carbohydrate); groups 2-9 (treat-
ment) were fed HCD, a standard rat chow supplemented
with 1% cholic acid, 2% pure cholesterol and 5.5% oil.
HCD-treated groups were gavage once every morning
for 28 days with the vehicle, simvastatin (3 mg/kg), PNS
(30 and 100 mg/kg), PDS (30 and 100 mg/kg) and PTS
(30 and 100 mg/kg). At the end of the feeding, the rats
were fasted overnight and sacrificed by cervical disloca-
tion. Blood, liver and aorta were collected for analysis.
This study was conducted according to protocols
approved by the Ethics Committee of Hong Kong Poly-
technic University.
Cell culture and treatment
HCAECs (Cambrex, USA) were cultured in EGM-2 MV
medium supplemented with SingleQuots kit (Cambrex,
USA), including hydrocortisone, hFGF, VEGF, IGF-1,
ascorbic acid, hEGF, R3-IGF-1, gentamicin/amphoteri-
cin-B, and 5% fetal bovine serum, at 37°C in a humidi-
fied 5% CO2 atmosphere. Cells with 85-90% confluence
from passages two to six were used for the experiments.
PNS, PDS and PTS stocks of 1 mg/ml as well as Rb1
and Rg1 stocks (1 μM) were dissolved in Milli-Q water.
The solutions were filtered through an Econofilter (0.22
μm, Agilent Technologies, USA). The samples were
added to cultured cells at different final concentrations
and incubated for 24 hours. To initiate an inflammatory
response, we added 10 ng/ml recombinant human
tumor necrosis factor-a (TNF-a; expressed in Escheri-
chia coli, Sigma, USA) to the medium. The mixture was
incubated with endothelial cells for four hours. Pyrroli-
dine dithiocarbamate (PDTC, purity > 99.0%; Sigma,
USA) was used as positive control and incubated for
two hours.
Cell adhesion assay
Monocyte adhesion was determined by the starved
THP-1 cells labeled with fluorescent dye Calcein-AM.
HCAECs (5 × 103 cells/well) were plated in 96-well
plates pretreated with various concentrations of different
samples, and subsequently stimulated with 10 ng/ml
TNF-a for four hours. Calcein-AM-labeled THP-1 cells
(5 × 103 cells/well) and TNF-a-activated HCAECs were
incubated together for 30 minutes. The total fluores-
cence intensity of each well was measured in a multi-
well plate reader (Wallac 1420, Germany) with excita-
tion at 485 nm and emission at 530 nm. Cells were then
washed with phosphate-buffered saline three times to
remove excess excess calcein-AM-labeled THP-1 cells.
The measurement was repeated.
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Cellular ELISA assay
Cellular ELISA, modified from Rothlein [14], was used
to measure the expression of ICAM-1 and VCAM-1 on
the surface of endothelial cells. Briefly, HCAECs grown
to confluence in a 96-well plate were treated with differ-
ent samples followed by stimulation with TNF-a (10
ng/ml). After fixation and blocking, cells were incubated
with anti-ICAM-1 (1:500) or anti-VCAM-1 (1:300) mAb
for one hour, then with horseradish peroxidase-conju-
gated goat anti-mouse IgG at VCAM-1 (1:200) or
ICAM-1 (1:400) respectively. Cells were exposed to the
peroxidase substrate, and absorbance at 490 nm was
measured in a fluorescence multi-well plate reader.
qRT-PCR analysis
Total RNA was extracted from HCAECs with RNeasy
mini kit (Qiagen, USA). SuperScript III® First-strand
synthesis system for real time RT-PCR (Invitrogen, USA)
was used to reverse-transcribe and amplify the mRNA
(0.7 μg) from each sample into cDNA. Oligonucleotide
primers and TaqMan® probes for human GAPDH,
ICAM-1 and VCAM-1 were purchased from Applied
Biosystems (USA). TaqMan® universal PCR master mix
(Applied Biosystems, USA) was used for quantitative
assay. Real time PCR was performed on an ABI PRISM
7500 Sequence Detection System (Applied Biosystems,
USA). All samples were assayed in triplicates and nor-
malized on the basis of their GAPDH content.
At the end of the feeding, rats were sacrificed and the
thoracic aorta (~15 mm) was rapidly dissected and
placed into Tyrode’s solution (NaCl 118 mM, KCl 4.7
mM, KH2PO4 1.2 mM, NaHCO3 25 mM, glucose 11
mM, CaCl2 2.5 mM, MgSO4 1.2 mM) at 4°C. The fat
and connective tissue adhering to the adventitia were
carefully cleaned from the aorta as much as possible
with surgical scissors under a dissecting microscope.
The total RNA of an isolated aorta was extracted with
TRIzol reagent (Invitrogen, USA) according to the man-
ufacturer’s protocols. The same amount of RNA (4.0 μg)
was reverse-transcribed and amplified into cDNA with a
RevertAid™ first strand synthesis kit (Fermentas,
Canada). Primers for the genes of interest were synthe-
sized by Shanghai Gene Core BioTechnologies, China
(Table 1). Real-time PCR was carried out with iQ™
SYBR® Green SuperMix (Bio-Rad, USA) and normalized
to GAPDH content.
Western blotting
HCAECs (50 × 104 cells/dish) grown to confluence in a
dish were pretreated with various concentrations of
PNS, PDS and PTS and stimulated with 10 ng/ml TNF-
a in 0.5% FBS medium for six hours. Cell pellets were
lysed in RIPA lysis buffer (USA) with 1% PMSF, 1% pro-
tease inhibitor cocktail and 1% sodium orthovanadate.
After treatment on ice for 30 minutes, cell lysates were
centrifuged (Beckman Coulter, USA) at 11, 419 × g for
30 minutes at 4°C to remove cell debris; the protein
content was measured with a BSA protein assay kit
(Pierce, USA). The aliquot lysates were subjected to 10%
SDS-PAGE (with 5% stacking gel) and transferred to a
PVDF membrane (Bio-Rad, USA). The membrane was
probed with mouse monoclonal antibody (mAb) against
ICAM-1 (1:1000) and VCAM-1 (1:500) followed by
horseradish peroxidase-conjugated secondary antibodies
diluted 1:7500 and 1:2000 respectively and visualized
with an ECL advanced western blotting detection kit
(Amersham, UK) according to the manufacturer’s proto-
col. Densitometric measurements of band intensity in
the Western blots were performed using Quantity One
software (Bio-Rad, USA).
Immunofluorescence staining
HCAECs were cultured in a 24-well plate. After fixed
with 80% ethanol for 10 minutes, the cells were incu-
bated with monoclonal antibody against p65 (1:100) for
one hour at room temperature, followed by incubation
with anti-mouse IgG Alexa 488 antibody (1:100) for 30
minutes. After washed with PBS for three times, the
cells were mixed with propidium iodide (1:1000) for ten
minutes and finally were examined and photographed
with a fluorescence microscope.
Statistical analysis
All values were expressed as mean ± SD. Differences
between groups were assessed by one-way analysis of var-
iance (ANOVA) with SPSS for Windows (version 15, USA).
The level of statistical significance was set at P < 0.05.
Results
Chemical characteristics of the tested fractions
The chemical characteristics of three fractions were deter-
mined to ensure quality consistency and standardization.
Under optimized chromatographic conditions [7], the
Table 1 Primer sequences used for quantitative real-time polymerase chain reaction
gene name Forward primer
(5’ to 3’)
Reverse primer
(5’ to 3’)
PCR product size (bp) GeneBank
accession no.
ICAM-1 AGACACAAGCAAGAGAAGAA GAGAAGCCCAAACCCGTATG 234 NM_012967.1
VCAM-1 GGAGCCTGTCAGTTTTGAGAATG TTGGGGAAAGAGTAGATGTCCAC 105 NM_012889.1
GAPDH TGCACCACCAACTGCTTAG AGTGGATGCAGGGATGATGT 180 NM_017008
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peaks corresponding to 11 chemical standards of different
saponins were well separated and identified in 60 minutes
(Figure 1A). Five compounds, namely notoginsenoside R1,
ginsenosides Rg1, Re, Rb1 and Rd, were clearly identified
as the major components of PNS (Figure 1B) and consti-
tuted approximately 90.2% of the total chemical composi-
tion of PNS. Among them, the first three saponins (ie
notoginsenoside R1, ginsenoside Rg1 and Re) were the
main components of the PTS fraction (Figure 1C) whereas
Rb1 and Rd were the major components of the PDS
fraction (Figure 1D). These compounds constituted
approximately 88.2% and 92.6% of the total chemical com-
position of the PTS and PDS fractions respectively. Figure
2 shows the chemical structures of ginsenosides Rg1 and
Rb1 from P. notoginseng.
Saponins inhibit monocyte adhesion on activated
endothelium
In order to identify which type of saponin was responsible
for the anti-atherogenic effect of the PNS fraction in vivo
Figure 1 HPLC-UV profiles of mixed standards (A), PNS (B), PTS (C), PDS (D) Peaks: 1, notoginsenoside R1; 2-11, ginsenoside Rg1, Re,
Rf, Rb1, Rg2, Rc, Rb2, Rb3, Rd and notoginsenoside K.
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[6], we compared saponin fractions (ie PNS, PTS and PDS)
and the ginsenosides (Rg1 and Rb1) for inhibitory activity
on THP-1 cells adhered to TNF-a-activated HCAECs,
mimicking an early step of the pathogenesis of athero-
sclerosis. A low level of adherence of monocytes to unsti-
mulated HCAECs was increased two-fold upon
stimulation with TNF-a (Figure 3). The PDTC (10 μg/ml)
positive control greatly reduced the adhesiveness of THP-
1. Endothelial cells pretreated with each of the different
samples of P. notoginseng exhibited dose-dependent but
different inhibitory effect on the TNF-a-induced adhesion
of monocytes to endothelial cells (Figure 3). After treat-
ment with the PNS (300 μg/ml), PDS (50 μg/ml) and PTS
(100 μg/ml) fractions, the monocyte-endothelial cell
adhesion was reduced by 24.6%, 41.9% and 32.8% respec-
tively. Comparison of the effective dose ranges and
corresponding relative inhibition rates showed that the
inhibitory effect of the PDS fraction on the adhesion of
THP-1 cells to TNF-a-stimulated HCAECs was more
potent than that of the PTS or PNS fraction. In addition,
Rb1 and Rg1 significantly and dose-dependently inhibited
the adhesion of THP-1 monocyte cells to TNF-a-stimu-
lated HCAECs; Rb1 (50 μM, 55.5 μg/ml) and Rg1 (30 μM,
24 μg/ml) decreased the adhesion by about 35% and 24%
respectively. In short, the trend of the inhibitory actions in
this in vitro assay was that PDS was more effective than
PTS which was more effective than PNS.
Saponins inhibit the expression of TNF-a-induced
endothelial adhesion molecules
To assess whether the fractions and ginsenosides modu-
late expression of TNF-a-induced adhesion molecules,
Figure 2 Chemical structures of ginsenosides Rg1 and Rb1.
Figure 3 Effects of fractions and ginsenosides from P. notoginseng on THP-1 cells adhesion to TNF-a-activated HCAECs. PDTC was used
as positive control. Bars represent mean ± SD (n = 3). ## P < 0.01 vs. control group; * P < 0.05 and ** P < 0.01 vs. TNF-a group.
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we examined the effect of PNS on TNF-a-induced sur-
face expression of ICAM-1 and VCAM-1 by immunos-
taining assay and cellular ELISA. The results (Figure 4)
showed that both ICAM-1 and VCAM-1 were expressed
at low levels on the unstimulated HCAECs. A 2-to-3-
fold increase was observed upon the stimulation with
TNF-a. These increases were inhibited dose-depen-
dently by all tested samples, except that the effect of
PTS on the expression of VCAM-1 was not significant
at the tested concentrations of 25-100 μg/ml (Figure
4B). PDTC (10 μg/ml) could almost normalize the
expression of ICAM-1 and VCAM-1 on HCAECs. Over-
all, the inhibitory potency of these saponin fractions on
TNF-a-induced expression of the CAMs exhibited a
trend similar to that of the monocyte-endothelial inter-
action, ie PDS was more effective than PTS which was
more effective than PNS.
Saponin fractions suppress the mRNA expressions of
ICAM-1 and VCAM-1 in HCAECs
The experiments described above demonstrated that
fractions and ginsenosides inhibited ICAM-1 and
VCAM-1 expression on the surface of stimulated
HCAECs. It is possible that they inhibit the expression
of these adhesion molecules by modulating the mRNA
level. For further investigation, the total RNA of
HCAECs was isolated and quantitatively assayed by
qRT-PCR (Figure 5A and 5B). Pretreatment of HCAECs
with the tested samples decreased the TNF-a-induced
production of ICAM-1 and VCAM-1 mRNA in
HCAECs. The level of inhibition of mRNA appeared to
be comparable with the results of the cell surface
expression experiments determined by cell ELISA.
Saponin fractions suppress the mRNA expressions of
ICAM-1 and VCAM-1 in HCD-fed rats
Rat thoracic aortas were isolated and the mRNA
expressions of ICAM-1 and VCAM-1 were examined.
Figure 6 shows that the expression of ICAM-1 and
VCAM-1 mRNA in the HCD rats was higher than
that in the control group. Treatment with simvastatin
(3 mg/kg per day), a common used cholesterol-lower-
ing drug, significantly inhibited the levels of ICAM-1
and VCAM-1 mRNA. Due to limited availability of
pure ginsenosides for in vivo study, only PNS, PDS
and PTS at the same dose range (30-100 mg/kg per
day) were tested and compared. The trend of inhibi-
tory action was similar to that found in the in vitro
assays (ie PDS was more potent than PTS which was
more potent than PNS) whereas the high dosage (100
Figure 4 Effects of fractions and ginsenosides from P. notoginseng on the surface expression of ICAM-1 (A) and VCAM-1 (B) protein in
TNF-a-stimulated HCAECs. Bars represent mean ± SD (n = 3). ## P < 0.01 vs. control group; * P < 0.05 and ** P < 0.01 vs. TNF-a group.
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Figure 6 Effects of fractions from P. notoginseng on the mRNA expression of ICAM-1 (A) and VCAM-1 (B) in the aortas from HCD-fed
rats. Data are expressed as mean ± SD (n = 6). * P < 0.05, ** P < 0.01 and *** P < 0.001 vs. control group. # P < 0.05, ## P < 0.01 and ### P <
0.001 vs. HCD group.
Figure 5 Effects of fractions and ginsenosides from P. notoginseng on the mRNA expression of ICAM-1 (A) and VCAM-1 (B) in HCAECs.
Data are expressed as mean ± SD (n = 3), ## P < 0.01 vs. control group; * P < 0.05 and ** P < 0.01 vs. TNF-a group.
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mg/kg per day) of the PDS fraction even suppressed
the up-regulated levels of ICAM-1 mRNA more effi-
ciently than treatment with simvastatin. Treatment of
the HCD rats with the saponin fractions showed dif-
ferential improvements in serum lipid profile and
blood vessel vasorelaxant activity (manuscript in
preparation).
Effects of the saponin fractions on the protein expression
of ICAM-1 and VCAM-1
Western blot analysis was used to investigate the effects
of the saponin fractions on TNF-a-stimulated protein
expressions of ICAM-1 and VCAM-1 in HCAECs.
HCAECs were pretreated with various concentrations of
saponin fractions for 24 hours and stimulated with
TNF-a for six hours. As shown in Figure 7, relatively
weak expressions of both CAMs were observed in the
control group and the protein expressions of both
CAMs increased significantly in TNF-a-stimulated
HCAECs. Although PNS and PTS fractions showed
slightly dose-dependent inhibitory effects on ICAM-1
and VCAM-1 expressions, no statistically significant dif-
ference was found. By contrast, the inhibitory effects of
the PDS fraction to VCAM-1 expression (but not to
ICAM-1 expression) were statistically significant (P =
0.0026).
Figure 7 Effects of fractions from P. notoginseng on the protein expression of ICAM-1 and VCAM-1 in TNF-a-stimulated HCAECs.
Samples was assayed in triplicates and normalized according to b-actin content. Data shown are expressed mean ± SD (n = 3). ## P < 0.01 vs.
control group; * P < 0.05 and ** P < 0.01 vs. TNF-a group.
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Effects of the saponin fractions on the nuclear
translocation of NF-B p65
The transcription factor NF-B plays a key role in
chronic inflammatory diseases, including atherosclerosis.
Pro-inflammatory cytokines including IL-1, IL-6 and
TNF-a can also induce inflammatory conditions and
was regulated by nuclear factor NF-B [15]. We used
immunofluorescence microscopy to investigate the
nuclear translocation of p65 as a surrogate marker for
the NF-B pathway activation. An Alexa fluor 488-con-
jugated secondary antibody against p65 was also used.
As shown in Figure 8, the control group demonstrated
that NF-B p65 was predominantly localized in the
cytoplasm. When the NF-B pathways were activated in
the TNF-a group, the translocation of NF-B p65 into
the nucleus was observed. In both the positive control
and all the treatment groups, the immunofluorescent
staining NF-B p65 in cellular nucleus was less intense
compared with the TNF-a group; however, we could
not quantitatively compare their effects in this qualita-
tive analysis.
Discussion
In the present study, the actions of three saponin frac-
tions (ie PNS, PDS and PTS) and two main ingredients
(ginsenosides Rg1 and Rb1) on inhibiting monocyte
adhesion in vitro and the expression of adhesion mole-
cules were conducted and compared. We demonstrated
that PNS, PDS and PTS exhibited different inhibitory
activity on monocyte adhesion on the activated endothe-
lial cells in vitro and the mRNA and cell surface expres-
sion of adhesion molecules, including ICAM-1 and
VCAM-1, on TNF-a-activated HCAECs in vitro, as well
as on the aorta of HCD-fed rats in vivo.
Many attempts have been made to establish a pivotal
role of inflammation in the initial stage of atherosclero-
sis [2]. Elevated levels of particular cytokines, such as
TNF-a and IL-6, can affect the arterial wall and cause
inflammation [16-18]. In this study, TNF-a was used to
activate the endothelial cells. Our data showed that
three saponin fractions and two ginsenosides of P. noto-
ginseng dramatically inhibited THP-1 monocyte cell
adhesion to TNF-a-stimulated HCAECs in a dose-
dependent manner. Among them, PDS showed the
strongest inhibitory effect. These results inspired us to
further investigate whether this inhibitory effect on cell-
cell adhesion was caused by the down-regulation of
CAMs in the HCAECs. Up-regulation of the CAMs
responsible for leukocyte-endothelium interaction plays
a crucial role in inflammation and atherogenesis [19].
As we expected, all tested fractions showed different
inhibitory effects on the expression of ICAM-1 and
VCAM-1 at both the protein and mRNA levels in vitro.
Interestingly, the PDS fraction showed a more potent
and effective anti-inflammation action on the TNF-a-
activated HCAECs in vitro compared to the PNS and
PTS fractions. More importantly, although Rb1 is the
most abundant compound, it is not as potent as the
whole PDS fraction. This finding suggests that other 20
(S)-protopanaxatriol saponins in PDS (eg Rg1, Re, R1,
Rg2 and Rh1) are likely to have the synergistic effects.
The in vivo effects of the three fractions on HCD-
induced atherosclerosis in rats were also examined.
These saponin fractions showed similar trends of differ-
ent degrees of beneficial effects on improving the vasor-
elaxant function of blood vessels and the serum lipid
profile (manuscript in preparation). Interestingly, PDS
showed a stronger inhibitory effect than the PTS and
PNS fractions on HCD-induced ICAM-1 and VCAM-1
mRNA levels in the rat aorta. Our in vitro and in vivo
data showed PDS to be the most effective fraction in
terms of inhibitory activity on the THP-1 monocyte cell
adhesion to TNF-a-stimulated HCAECs as well as the
expression of CAMs in the TNF-a-stimulated HCAECs
and the aorta of the HCD-fed rat. However, we observed
some discrepancies of the expression of VCAM-1 and
ICAM-1 at both the mRNA and protein levels. CAMs is
a protein family including VCAM-1, ICAM-1, E-selectin,
P-selectin, PECAM-1 and mucosal addressin CAM-1
(MAdCAM-1). Only the two major members of the pro-
tein family, namely VCAM-1 and ICAM-1, were investi-
gated in this study. It has been reported [20,21] that
antioxidant agents such as PDTC and proanthocyanidin
extract markedly attenuate the TNF-a-induced expres-
sion of VCAM-1 but not ICAM-1 in endothelial cells.
These results provide insights into why anti-vascular
inflammatory compounds elicit different transcriptional
and translational regulation on CAMs.
It is well known that NF-B controls the transcription
of many genes with an established role in atherosclero-
sis, such as cytokines, chemokines, adhesion molecules,
and macrophage infiltration [22]. NF-B is inactive in
the cytoplasm of the normal cells because it is bound to
IB. Once NF-B is activated, degradation of IB and
the subsequent nuclear translocation of p65 as a surro-
gate of active NF-B take place [23]. TNF-a as well as
LPS and IL-1b may lead to the transcriptional activation
of NF-B in endothelial cells. In this study, we deter-
mined whether the protection of P. notoginseng saponins
against vascular inflammation is associated with the reg-
ulation of the NF-B pathway in endothelial cells. Fluor-
escent immunostaining experiment showed that all the
saponin fractions reduced NF-B p65 nuclear immuno-
fluorescent staining in comparison with the TNF-a
group. These results confirmed that the saponin frac-
tions of P. notoginseng exhibit anti-vascular inflamma-
tory activity probably through the inhibition of NF-B
activation. In addition, the inhibitory effects of the
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saponin fractions of P. notoginseng on adhesion mole-
cules expressions observed in the adhesion assay, cell-
ELISA, western blotting and real-time PCR analysis may
be attributed to their NF-B inhibitory actions.
Our earlier studies showed that P. notoginseng is
unique and has high economic and therapeutic values
due to its large quantity of Rg1 and Rb1 which is consid-
erably larger than both the Asian ginseng (Panax
Figure 8 Effects of fractions from P. notoginseng on NF-B/p65 nuclear translocation. NF-B/p65 expression was labeled with anti-NF-B/
p65 antibody and an Alexa fluor 488-conjugated secondary antibody (green). Magnification × 400
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ginseng C. A. Mey) and American ginseng (Panax quin-
quefolius L.) [24]. Moreover, notoginsenoside R1 is
unique in P. notoginseng. Interestingly, the ratios of Rg1/
Re and Rg1/Rb1 are higher in P. notoginseng compared
to the other ginseng species. Our earlier studies showed
that P. notoginseng saponins (PNS) is a potential anti-
atherogenic agent [6] as well as a potential angiogenic
agent for angiogenesis therapy [25]. The present study
showed for the first time that the PDS fraction of P.
notoginseng is the most active agent for the suppression
of monocyte adhesion to activate endothelial cells in
vitro and the expression of endothelial adhesion mole-
cules in vitro and in vivo.
Conclusion
The present study demonstrates potential anti-athero-
genic effects of the saponin fractions (PNS, PDS and
PTS) and major ginsenosides (Rg1 and Rb1). Among the
fractions, PDS is the most effective one against TNF-a-
induced cell-cell adhesion and expression of adhesion
molecules in vitro and in vivo.
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